Despite developing a similar degree of hyperglycaemia to untreated diabetic WT controls (Fig. 4a), anti-IL-17 Ab treatment significantly attenuated albuminuria at 12 weeks (Fig. 4b). Here, IL17A is linked to Hyperglycemia.